Literature DB >> 24413534

VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.

Anna Fantozzi1, Dorothea C Gruber, Laura Pisarsky, Chantal Heck, Akiko Kunita, Mahmut Yilmaz, Nathalie Meyer-Schaller, Karen Cornille, Ulrike Hopfer, Mohamed Bentires-Alj, Gerhard Christofori.   

Abstract

An epithelial-mesenchymal transition (EMT) underlies malignant tumor progression and metastatic spread by enabling cancer cells to depart from the primary tumor, invade surrounding tissue, and disseminate to distant organs. EMT also enriches for cancer stem cells (CSC) and increases the capacity of cancer cells to initiate and propagate tumors upon transplantation into immune-deficient mice, a major hallmark of CSCs. However, the molecular mechanisms promoting the tumorigenicity of cancer cells undergoing an EMT and of CSCs have remained widely elusive. We here report that EMT confers efficient tumorigenicity to murine breast cancer cells by the upregulated expression of the proangiogenic factor VEGF-A and by increased tumor angiogenesis. On the basis of these data, we propose a novel interpretation of the features of CSCs with EMT-induced, VEGF-A-mediated angiogenesis as the connecting mechanism between cancer cell stemness and tumor initiation. ©2014 AACR

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413534     DOI: 10.1158/0008-5472.CAN-13-1641

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  78 in total

1.  Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion.

Authors:  Cristina Vanni; Marzia Ognibene; Federica Finetti; Patrizia Mancini; Sara Cabodi; Daniela Segalerba; Maria Rosaria Torrisi; Sandra Donnini; Maria Carla Bosco; Luigi Varesio; Alessandra Eva
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.

Authors:  Nathaniel J Robinson; Derek J Taylor; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-06

3.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

4.  Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.

Authors:  Hea Nam Hong; You Jin Won; Ju Hee Shim; Hyun Ji Kim; Seung Hee Han; Byung Sik Kim; Hee Sung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-12       Impact factor: 4.553

5.  Tumor suppressor control of the cancer stem cell niche.

Authors:  K Kramer; J Wu; D L Crowe
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

6.  The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice.

Authors:  Ryota Shizu; Mai Ishimura; Sumihito Nobusawa; Takuomi Hosaka; Takamitsu Sasaki; Satoru Kakizaki; Kouichi Yoshinari
Journal:  Arch Toxicol       Date:  2021-01-04       Impact factor: 5.153

Review 7.  Targeting angiogenesis in small cell lung cancer.

Authors:  Michalis Stratigos; Alexios Matikas; Alexandra Voutsina; Dimitrios Mavroudis; Vassilis Georgoulias
Journal:  Transl Lung Cancer Res       Date:  2016-08

8.  Thiol-ene hydrogels as desmoplasia-mimetic matrices for modeling pancreatic cancer cell growth, invasion, and drug resistance.

Authors:  Chang Seok Ki; Tsai-Yu Lin; Murray Korc; Chien-Chi Lin
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

9.  A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.

Authors:  Jiangang Yu; Xiaohong Liao; Luying Li; Lei Lv; Xiuling Zhi; Jerry Yu; Ping Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-26       Impact factor: 2.416

Review 10.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.